Literature DB >> 12916130

HIV transmission risk behavior and its relation to antiretroviral treatment adherence.

Rachel C Flaks1, William J Burman, Patrick J Gourley, Cornelis A Rietmeijer, David L Cohn.   

Abstract

BACKGROUND: Rising rates of antiretroviral drug resistance among recently infected persons are evidence of high-risk behavior among persons in HIV care. GOAL: The goal was to determine HIV transmission risk behavior among persons in HIV care and evaluate its association with treatment adherence. STUDY
DESIGN: The study involved a structured interview of a random sample of patients in HIV care in an urban public clinic. Participants were categorized by transmission risk: high risk = unprotected anal/vaginal sex and/or needle sharing; low risk = protected anal/vaginal sex, unprotected and/or protected oral sex, no needle sharing; no risk = no sex or needle sharing.
RESULTS: Of the 95 participants, 21 (22%) reported high-risk behavior, 36 (38%) reported low-risk behavior, and 38 (40%) reported no transmission risk in the past 3 months. Younger, more educated persons and those with an active substance abuse diagnosis were more likely to have high transmission risk (P < or = 0.05). Patients who engaged in high-risk behavior had equivalent use of antiretroviral therapy (P = 0.80) but lower adherence (P < or = 0.01) and higher median plasma viral loads (P = 0.05).
CONCLUSIONS: There was a wide spectrum of transmission risk behavior among persons in HIV care. Persons reporting high-risk behavior were less adherent to antiretroviral therapy, providing a behavioral basis for transmission of drug-resistant HIV.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12916130     DOI: 10.1097/00007435-200305000-00005

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  11 in total

1.  Predictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settings.

Authors:  Kartik K Venkatesh; A K Srikrishnan; Kenneth H Mayer; N Kumarasamy; Sudha Raminani; E Thamburaj; Lakshmi Prasad; Elizabeth W Triche; Suniti Solomon; Steven A Safren
Journal:  AIDS Patient Care STDS       Date:  2010-11-22       Impact factor: 5.078

2.  The effect evaluation of highly active antiretroviral therapy to patients with AIDS in Hubei province of China.

Authors:  Xuehua Li; Yihua Xu; Shaofa Nie; Hao Xiang; Chongjian Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-10-11

Review 3.  Integrating HIV prevention activities into the HIV medical care setting: a report from the NYC HIV Centers Consortium.

Authors:  Tracey E Wilson; David Vlahov; Stephen Crystal; Judith Absalon; Susan J Klein; Robert H Remien; Robert H Remein; Bruce Agins
Journal:  J Urban Health       Date:  2006-01       Impact factor: 3.671

4.  Transmitted resistance to HIV integrase strand-transfer inhibitors: right on schedule.

Authors:  Christopher B Hurt
Journal:  Antivir Ther       Date:  2011

5.  Stages of change for adherence to antiretroviral medications.

Authors:  Becky L Genberg; Yoojin Lee; William H Rogers; Cynthia Willey; Ira B Wilson
Journal:  AIDS Patient Care STDS       Date:  2013-10       Impact factor: 5.078

6.  Mental health treatment to reduce HIV transmission risk behavior: a positive prevention model.

Authors:  Kathleen J Sikkema; Melissa H Watt; Anya S Drabkin; Christina S Meade; Nathan B Hansen; Brian W Pence
Journal:  AIDS Behav       Date:  2010-04

7.  Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial.

Authors:  William Burman; Birgit Grund; Jacqueline Neuhaus; John Douglas; Gerald Friedland; Edward Telzak; Robert Colebunders; Nicholas Paton; Martin Fisher; Cornelis Rietmeijer
Journal:  J Acquir Immune Defic Syndr       Date:  2008-10-01       Impact factor: 3.731

Review 8.  Secondary prevention of HIV infection: the current state of prevention for positives.

Authors:  Jeffrey D Fisher; Laramie Smith
Journal:  Curr Opin HIV AIDS       Date:  2009-07       Impact factor: 4.283

9.  Opportunities for sexual transmission of antiretroviral drug resistance among HIV-infected patients in care.

Authors:  Heidi M Soeters; Sonia Napravnik; Oksana M Zakharova; Joseph J Eron; Christopher B Hurt
Journal:  AIDS       Date:  2013-11-28       Impact factor: 4.177

10.  Prospective predictors of unprotected anal intercourse among HIV-seropositive men who have sex with men initiating antiretroviral therapy.

Authors:  David W Pantalone; David Huh; Kimberly M Nelson; Cynthia R Pearson; Jane M Simoni
Journal:  AIDS Behav       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.